Cargando…

Pharmacokinetics and Safety of Ceftobiprole in Pediatric Patients

Ceftobiprole, the active moiety of the prodrug ceftobiprole medocaril, is an advanced-generation, broad-spectrum, intravenous cephalosporin, which is currently approved for the treatment of adults with hospital-acquired or community-acquired pneumonia. METHODS: Noncompartmental pharmacokinetics and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rubino, Christopher M., Polak, Mark, Schröpf, Sebastian, Münch, Hans Georg, Smits, Anne, Cossey, Veerle, Tomasik, Tomasz, Kwinta, Przemko, Snariene, Rima, Liubsys, Arunas, Gardovska, Dace, Hornik, Chi Dang, Bosheva, Miroslava, Ruehle, Christine, Litherland, Karine, Hamed, Kamal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Antimicrobial Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505155/ https://www.ncbi.nlm.nih.gov/pubmed/34533489 http://dx.doi.org/10.1097/INF.0000000000003296

Ejemplares similares

Model-Based Approach for Optimizing Ceftobiprole Dosage in Pediatric Patients
por: Rubino, Christopher M., et al.
Publicado: (2021)

A Phase 3, Randomized, Investigator-blinded Trial Comparing Ceftobiprole With a Standard-of-care Cephalosporin, With or Without Vancomycin, for the Treatment of Pneumonia in Pediatric Patients
por: Bosheva, Miroslava, et al.
Publicado: (2021)

Ceftobiprole: a clinical view
por: Pérez-Crespo, Pedro María Martínez, et al.
Publicado: (2021)

Ceftobiprole medocaril
por: Méndez, Raúl, et al.
Publicado: (2022)

2561. Population Pharmacokinetic Analyses for Ceftobiprole Using Data from Phase 1 and 3 Studies
por: Cammarata, Anthony P, et al.
Publicado: (2023)

2532. Pharmacokinetic-Pharmacodynamic Analyses for Ceftobiprole Efficacy Based on Phase 3 Data from Patients with Staphylococcus aureus Bacteremia
por: Bhavnani, Sujata M, et al.
Publicado: (2023)

2531. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Ceftobiprole Dosing Regimens for Patients with Staphylococcus aureus Bacteremia (SAB)
por: Bhavnani, Sujata M, et al.
Publicado: (2023)

Ceftobiprole Medocaril Is an Effective Post-Exposure Treatment in the Fischer 344 Rat Model of Pneumonic Tularemia
por: Hahn, Mark M., et al.
Publicado: (2023)

Safety and tolerability of ceftobiprole
por: Grau, Santiago
Publicado: (2019)

Ceftobiprole for the treatment of pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2019)

Evaluation of irisin and visfatin levels in very low birth weight preterm newborns compared to full term newborns—A prospective cohort study
por: Mól, Nina, et al.
Publicado: (2018)

Possible clinical indications of ceftobiprole
por: Barberán, José
Publicado: (2019)

2530. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Ceftobiprole Dose Selection for the Treatment of Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI) and Community-Acquired Bacterial Pneumonia (CABP)
por: Bhavnani, Sujata M, et al.
Publicado: (2023)

Activity of Plazomicin (ACHN-490) against MDR clinical isolates of Klebsiella pneumoniae, Escherichia coli, and Enterobacter spp. from Athens, Greece
por: Galani, Irene, et al.
Publicado: (2012)

Micafungin in Premature and Non-premature Infants: A Systematic Review of 9 Clinical Trials
por: Manzoni, Paolo, et al.
Publicado: (2014)

Clinical Experience with Daptomycin for the Treatment of Gram-positive Infections in Children and Adolescents
por: Syriopoulou, Vassiliki, et al.
Publicado: (2016)

A Phase 3 Study of Micafungin Versus Amphotericin B Deoxycholate in Infants With Invasive Candidiasis
por: Benjamin, Daniel K., et al.
Publicado: (2018)

Safety, Tolerability and Pharmacokinetics of MEDI8897, an Extended Half-life Single-dose Respiratory Syncytial Virus Prefusion F-targeting Monoclonal Antibody Administered as a Single Dose to Healthy Preterm Infants
por: Domachowske, Joseph B., et al.
Publicado: (2018)

Antibiotic Resistance Among Pediatric-Sourced Ocular Pathogens: 8-Year Findings From the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) Surveillance Study
por: Alter, Sherman J., et al.
Publicado: (2019)

Exploiting Homoplasy in Genome-Wide Association Studies to Enhance Identification of Antibiotic-Resistance Mutations in Bacterial Genomes
por: Lai, Yi-Pin, et al.
Publicado: (2020)

A Novel Cecropin D-Derived Short Cationic Antimicrobial Peptide Exhibits Antibacterial Activity Against Wild-Type and Multidrug-Resistant Strains of Klebsiella pneumoniae and Pseudomonas aeruginosa
por: Ocampo-Ibáñez, Iván Darío, et al.
Publicado: (2020)

Baloxavir Marboxil Single-dose Treatment in Influenza-infected Children: A Randomized, Double-blind, Active Controlled Phase 3 Safety and Efficacy Trial (miniSTONE-2)
por: Baker, Jeffrey, et al.
Publicado: (2020)

Baloxavir Marboxil 2% Granules in Japanese Children With Influenza: An Open-label Phase 3 Study
por: Yokoyama, Takato, et al.
Publicado: (2020)

Draft Genome Sequence of Ciprofloxacin and Ceftriaxone Resistant Campylobacter jejuni MM26-781 Assigned to Novel ST Isolated From Common Pigeon in Lithuania
por: Aksomaitiene, Jurgita, et al.
Publicado: (2019)

Molecular Docking of Broad-Spectrum Antibodies on Hemagglutinins of Influenza A Virus
por: Le, Khanh PB, et al.
Publicado: (2019)

Simulated Comparison of a Bayesian Clinical Decision Support System Versus Standard of Care For Achieving Gentamicin Pharmacokinetic Targets in Neonates
por: Yu, Collin Z., et al.
Publicado: (2020)

Safety, Efficacy and Pharmacokinetics of Anidulafungin in Patients 1 Month to <2 Years of Age With Invasive Candidiasis, Including Candidemia
por: Roilides, Emmanuel, et al.
Publicado: (2020)

Evaluation of Ceftriaxone Plus Avibactam in an Intracellular Hollow Fiber Model of Tuberculosis: Implications for the Treatment of Disseminated and Meningeal Tuberculosis in Children
por: Srivastava, Shashikant, et al.
Publicado: (2020)

Prevalence and risk analysis of mobile colistin resistance and extended-spectrum β-lactamase genes carriage in pet dogs and their owners: a population based cross-sectional study
por: Lei, Lei, et al.
Publicado: (2021)

Characterization of an NDM-5-producing hypervirulent Klebsiella pneumoniae sequence type 65 clone from a lung transplant recipient
por: Zhao, Jiankang, et al.
Publicado: (2021)

Pan-drug resistant Providencia rettgeri contributing to a fatal case of COVID-19
por: Mc Gann, Patrick, et al.
Publicado: (2021)

Increasingly limited options for the treatment of enteric fever in travellers returning to England, 2014–2019: a cross-sectional analytical study
por: Herdman, M. Trent, et al.
Publicado: (2021)

Construction and evaluation of a bioluminescent Pseudomonas aeruginosa reporter for use in preservative efficacy testing
por: Rushton, Laura, et al.
Publicado: (2021)

Emergence of carbapenem-resistant Klebsiella pneumoniae harbouring bla (OXA-48)-like genes in China
por: Chen, Ying, et al.
Publicado: (2021)

The epidemiology of AmpC-producing Escherichia coli isolated from dairy cattle faeces on pasture-fed farms
por: Burgess, Sara A., et al.
Publicado: (2021)

Prevalence of genotypic antimicrobial resistance in clinical Shiga toxin-producing Escherichia coli in Norway, 2018 to 2020
por: Ramstad, Silje N., et al.
Publicado: (2021)

Impact of growth media and pressure on the diversity and antimicrobial activity of isolates from two species of hexactinellid sponge
por: Koch, Matthew J., et al.
Publicado: (2021)

The genetic basis of phage susceptibility, cross-resistance and host-range in Salmonella
por: Adler, Benjamin A., et al.
Publicado: (2021)

Cryo-EM structure of Mycobacterium tuberculosis 50S ribosomal subunit bound with clarithromycin reveals dynamic and specific interactions with macrolides
por: Zhang, Wen, et al.
Publicado: (2022)

Methicillin-resistant Staphylococcus aureus in China: a multicentre longitudinal study and whole-genome sequencing
por: Wang, Bingjie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_88kj4l7lskq1rsqlshelfgqebg